Patent Law Weblog
Month: May 2007
-
The significance of the Supreme Court's decision in KSR Int'l Co. v. Teleflex Inc. can be measured, at least in part, by the array of CLE's that have been announced only days after the Court issued its opinion. Among the CLE's now be offered are the following: West LEGALworks® will be offering a webcast entitled:…
-
By Jason Derry & Christopher P. Singer — After one year of service, it’s pretty safe to say that the U.S. Patent Office got it right with the EFS-Web electronic patent filing system. No more waiting to get that postcard back to ensure your filing date. No more midnight runs to the 24-hour…
-
By Kevin E. Noonan — The potential effect of the Supreme Court’s ruling in KSR Int’l Co. v. Teleflex Inc. on practice before the U.S. Patent and Trademark Office has created the most anxiety among patent applicants and their representatives at the patent bar. This is because the opinion is replete with dicta…
-
As many of our readers know, the 2007 BIO International Convention is rapidly approaching. BIO 2007 will be held May 6-9 in Boston, Massachusetts, at the Boston Convention and Exhibition Center. Patent Docs authors Kevin Noonan, Sherri Oslick, and Mark Chael will all be in attendance at BIO and they would welcome the opportunity to…
-
By Kevin E. Noonan — There is a growing trend in developing countries (such as Brasil, China, India, and Thailand) for their governments to avail themselves of the ability under prevailing international trade agreements to grant compulsory licenses or permit so-called "parallel imports" of generic drugs in the face of national patents procured…
-
By Kevin E. Noonan — In just the latest in a series of developments unwelcomed by Western drug companies, Brasil has threatened to distribute a generic version of Merck & Co.’s anti-AIDS drug efavirenz (Stocrin®). This action is consistent with earlier steps taken by Brasil, as well as Thailand, that thwart the intentions…
Patent Docs 